Skip to main content

Table 4 Life-support therapy during hospital stay in the study population of 1,488 patients with septic shock (EPISS study - 2009 to 2011).

From: The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study

Treatment n (%) Median (IQR) duration
(days)
Vasopressors 1,488 (100%) 4 (2-6)
Inotropes 412 (27.7%) 3 (2-6)
Invasive mechanical ventilation 1,248 (83.9%) 7 (3-14)
Non-invasive ventilation 355 (24.2%) 2 (1-4)
Continuous renal replacement therapy 484 (32.5%) 4 (2-8)
Intermittent hemodialysis 291 (19.6%) 3 (1-5)
Hydrocortisone 937 (63.0%) N/A
Protein C 28 (1.9%) N/A
  1. IQR, interquartile range; N/A, not available.